STAR SIGN study: Evaluation of COVID‐19 vaccine efficacy against the SARS‐CoV‐2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease

Simon Woelfel, Joel Dütschler, Marius König, Alex Dulovic, Nicole Graf, Daniel Junker, Vasileios Oikonomou, Claudia Krieger, Samuel Truniger, Annett Franke, Annika Eckhold, Kristina Forsch, Seraina Koller, Jacqueline Wyss, Niklas Krupka, Melanie Oberholzer, Nicola Frei, Nora Geissler, Peter Schaub, Unknown, Werner C. Albrich, Matthias Friedrich, Nicole Schneiderhan‐Marra, Benjamin Misselwitz, Wolfgang Korte, Justus J. Bürgi, Stephan Brand

Open source

DOI: 10.1111/apt.17661
Published: 2023-08-12
Container: Alimentary Pharmacology & Therapeutics
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/apt.17661,
  title = {STAR SIGN study: Evaluation of COVID‐19 vaccine efficacy against the SARS‐CoV‐2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease},
  author = {Simon Woelfel and Joel Dütschler and Marius König and Alex Dulovic and Nicole Graf and Daniel Junker and Vasileios Oikonomou and Claudia Krieger and Samuel Truniger and Annett Franke and Annika Eckhold and Kristina Forsch and Seraina Koller and Jacqueline Wyss and Niklas Krupka and Melanie Oberholzer and Nicola Frei and Nora Geissler and Peter Schaub and Unknown and Werner C. Albrich and Matthias Friedrich and Nicole Schneiderhan‐Marra and Benjamin Misselwitz and Wolfgang Korte and Justus J. Bürgi and Stephan Brand},
  year = {2023},
  journal = {Alimentary Pharmacology \&amp; Therapeutics},
  doi = {10.1111/apt.17661},
  url = {https://doi.org/10.1111/apt.17661}
}

RIS

TY  - JOUR
TI  - STAR SIGN study: Evaluation of COVID‐19 vaccine efficacy against the SARS‐CoV‐2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease
AU  - Simon Woelfel
AU  - Joel Dütschler
AU  - Marius König
AU  - Alex Dulovic
AU  - Nicole Graf
AU  - Daniel Junker
AU  - Vasileios Oikonomou
AU  - Claudia Krieger
AU  - Samuel Truniger
AU  - Annett Franke
AU  - Annika Eckhold
AU  - Kristina Forsch
AU  - Seraina Koller
AU  - Jacqueline Wyss
AU  - Niklas Krupka
AU  - Melanie Oberholzer
AU  - Nicola Frei
AU  - Nora Geissler
AU  - Peter Schaub
AU  - Unknown
AU  - Werner C. Albrich
AU  - Matthias Friedrich
AU  - Nicole Schneiderhan‐Marra
AU  - Benjamin Misselwitz
AU  - Wolfgang Korte
AU  - Justus J. Bürgi
AU  - Stephan Brand
PY  - 2023
JO  - Alimentary Pharmacology &amp; Therapeutics
DO  - 10.1111/apt.17661
UR  - https://doi.org/10.1111/apt.17661
ER  -

APA

Woelfel, S., Dütschler, J., König, M., Dulovic, A., Graf, N., Junker, D., Oikonomou, V., Krieger, C., Truniger, S., Franke, A., Eckhold, A., Forsch, K., Koller, S., Wyss, J., Krupka, N., Oberholzer, M., Frei, N., Geissler, N., Schaub, P., Unknown, Albrich, W. C., Friedrich, M., Schneiderhan‐Marra, N., Misselwitz, B., Korte, W., Bürgi, J. J., & Brand, S. (2023). STAR SIGN study: Evaluation of COVID‐19 vaccine efficacy against the SARS‐CoV‐2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17661

Source records

crossref · retrieved 2026-09-25T16:26:10.194Z